Delivery Order SPE2DB20D1047-SPE2DB25FF86W
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Viberzi 75 mg tablets (60-count units) under a firm fixed-price contract with a ceiling value of $1,707.63. This non-set-aside competitive award represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The place of performance is the contractor's corporate office location in Conshohocken, Pennsylvania, with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Viberzi 100 mg tablets (60-count units) valued at $1,325.08. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 24, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $3,415.26 to AmerisourceBergen Drug Corp for the supply of Viberzi 100 mg tablets (60-count package). This firm fixed-price, competitively awarded delivery order was issued on August 7, 2025, with an ultimate completion date of August 8, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. The contract represents a continuation of...
- The Defense Logistics Agency awarded a delivery order valued at $2,711.03 to AmerisourceBergen Drug Corp for 60 tablets of Viberzi 100 mg, a pharmaceutical product for gastrointestinal treatment. This competitively awarded, non-set-aside contract employs firm fixed pricing and carries an ultimate completion date of May 19, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a...
- The Defense Logistics Agency awarded a $2,136.20 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Viberzi 75 mg tablets (60-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 29, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, the pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania, on July 24, 2025, for the supply of Viberzi 100 mg tablets (60-count). This firm fixed price delivery order, valued at $1,184.87, is classified as a non-set-aside contract and is expected to reach ultimate completion by July 25, 2025, with performance occurring at AmerisourceBergen's Conshohocken...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Viberzi 100 mg tablets (60-count) under a firm fixed-price contract valued at $1,734.24. This is a competitively awarded, non-set-aside delivery order with an ultimate completion date of August 29, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of VIBERZI 100 MG tablets (60-count units) valued at $1,138.42 under a firm fixed-price contract. This award, which carries an ultimate completion date of August 8, 2025, represents a child delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Viberzi 100 mg tablets (60-count) at a firm fixed price of $1,138.42. This non-set-aside contract, with an ultimate completion date of August 1, 2025, represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,918.41 by the Defense Logistics Agency (DLA) on September 17, 2025. The contract, issued under firm fixed price terms with no set-aside designation, covers the supply of Viberzi 100 mg tablets in a quantity of 60 units, with an ultimate completion date of September 18, 2025. This delivery order represents a child contract under AmerisourceBergen's...
- SPE2DB20D1047Indefinite Delivery Contract
- SPE2DB20D1047-SPE2DB25FF86WDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Viberzi 100 mg tablets (60-count), a pharmaceutical product with a contract ceiling value of $1,761.21. This non-set-aside, competitively awarded delivery order represents a firm fixed price transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is part of AmerisourceBergen's comprehensive pharmaceutical support vehicle for the DLA, which enables the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor headquartered in Pennsylvania, AmerisourceBergen serves as a critical federal vendor for medical procurement through the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's contract portfolio with DLA demonstrates its capability to fulfill diverse federal medical supply requirements across multiple therapeutic domains, from specialty medications to generic drugs and medical devices.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 9/22/25 |